MedTrace Logo

Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program

NCT03628638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1718

Last updated 2021-02-15

No results posted yet for this study

Summary

The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.

Conditions

  • Healthy

Interventions

OTHER

Blood Sample Collection

Subjects participating in the study will have blood sample collected at enrollment. . For any subjects scheduled for a 12 month follow-up, additional blood samples will be collected at 12 months from enrollment.

Sponsors & Collaborators

  • Exact Sciences Corporation

    lead INDUSTRY

Principal Investigators

  • Laura Strong · Exact Sciences

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03628638 on ClinicalTrials.gov